Core Scientific Inc a un objectif de cours consensuel de $21.56 basé sur les évaluations de 20 analystes. Le plus élevé est $34, publié par Macquarie le octobre 31, 2025. Le plus bas est $14.5, publié par Ladenburg Thalmann le juillet 2, 2024. Les 3 évaluations d’analystes les plus récentes ont été publiées par Bernstein, Macquarie et HC Wainwright & Co. le novembre 3, 2025, octobre 31, 2025 et octobre 28, 2025, respectivement. Avec un objectif de cours moyen de $27.67 entre Bernstein, Macquarie et HC Wainwright & Co., il existe une variation implicite de 34.30% upside pour Core Scientific Inc selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 16.5% | Bernstein | $17 → $24 | Maintains | Outperform | |||
10/31/2025 | 65.05% | Macquarie | $18 → $34 | Upgrade | Neutral → Outperform | |||
10/28/2025 | 21.36% | HC Wainwright & Co. | → $25 | Upgrade | Neutral → Buy | |||
10/28/2025 | 11.65% | Clear Street | $14 → $23 | Upgrade | Hold → Buy | |||
10/27/2025 | 21.36% | HC Wainwright & Co. | → $25 | Upgrade | Neutral → Buy | |||
10/24/2025 | 26.21% | Cantor Fitzgerald | $18 → $26 | Maintains | Overweight | |||
10/23/2025 | 14.08% | Roth Capital | $17 → $23.5 | Upgrade | Neutral → Buy | |||
09/29/2025 | -12.62% | Macquarie | $15 → $18 | Maintains | Neutral | |||
08/22/2025 | -17.48% | Roth Capital | $20 → $17 | Maintains | Neutral | |||
08/19/2025 | -27.18% | Macquarie | $15 → $15 | Maintains | Neutral | |||
08/18/2025 | 6.8% | Jefferies | $16 → $22 | Maintains | Buy | |||
08/12/2025 | — | JMP Securities | — | Reiterates | Market Perform → Market Perform | |||
08/11/2025 | — | HC Wainwright & Co. | — | Reiterates | Neutral → Neutral | |||
07/14/2025 | -27.18% | JMP Securities | $15 → $15 | Downgrade | Market Outperform → Market Perform | |||
07/10/2025 | -27.18% | Macquarie | $15 → $15 | Downgrade | Outperform → Neutral | |||
07/10/2025 | — | Needham | — | Downgrade | Buy → Hold | |||
07/08/2025 | -2.91% | Roth Capital | $20 → $20 | Downgrade | Buy → Neutral | |||
07/08/2025 | — | HC Wainwright & Co. | — | Downgrade | Buy → Neutral | |||
07/07/2025 | -2.91% | BTIG | → $20 | Downgrade | Buy → Neutral | |||
07/07/2025 | — | Oppenheimer | — | Downgrade | Outperform → Perform | |||
06/27/2025 | -17.48% | Canaccord Genuity | $17 → $17 | Maintains | Buy | |||
06/27/2025 | -12.62% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
06/26/2025 | -2.91% | Roth MKM | $20 → $20 | Maintains | Buy | |||
06/10/2025 | -12.62% | Needham | $16 → $18 | Maintains | Buy | |||
05/22/2025 | -27.18% | JMP Securities | → $15 | Initiates | → Market Outperform | |||
05/16/2025 | -22.33% | Needham | $16 → $16 | Reiterates | Buy → Buy | |||
05/14/2025 | -27.18% | Oppenheimer | → $15 | Initiates | → Outperform | |||
05/09/2025 | -17.48% | Canaccord Genuity | $17 → $17 | Maintains | Buy | |||
04/09/2025 | -2.91% | Roth MKM | $23 → $20 | Maintains | Buy | |||
03/12/2025 | -17.48% | Canaccord Genuity | $17 → $17 | Maintains | Buy | |||
03/11/2025 | -17.48% | HC Wainwright & Co. | $17 → $17 | Reiterates | Buy → Buy | |||
02/27/2025 | 11.65% | Roth MKM | $25.5 → $23 | Maintains | Buy | |||
02/27/2025 | 1.94% | Cantor Fitzgerald | $24 → $21 | Maintains | Overweight | |||
02/27/2025 | -17.48% | Needham | $18 → $17 | Maintains | Buy | |||
02/27/2025 | -17.48% | HC Wainwright & Co. | $17 → $17 | Reiterates | Buy → Buy | |||
02/27/2025 | -17.48% | Canaccord Genuity | $17 → $17 | Maintains | Buy | |||
02/25/2025 | -2.91% | Compass Point | $26 → $20 | Maintains | Buy | |||
01/21/2025 | 16.5% | Craig-Hallum | → $24 | Initiates | → Buy | |||
01/17/2025 | -12.62% | Needham | $18 → $18 | Reiterates | Buy → Buy | |||
12/16/2024 | -2.91% | BTIG | $19 → $20 | Maintains | Buy | |||
12/12/2024 | — | Jones Trading | — | Initiates | → Hold | |||
11/15/2024 | -7.77% | BTIG | $15 → $19 | Maintains | Buy | |||
11/15/2024 | 23.79% | Roth MKM | → $25.5 | Initiates | → Buy | |||
11/14/2024 | -7.77% | Macquarie | $16 → $19 | Maintains | Outperform | |||
11/07/2024 | -17.48% | B. Riley Securities | $16 → $17 | Maintains | Buy | |||
11/07/2024 | -17.48% | Canaccord Genuity | $17 → $17 | Maintains | Buy | |||
11/07/2024 | -17.48% | HC Wainwright & Co. | $15 → $17 | Maintains | Buy | |||
11/07/2024 | -12.62% | Needham | $17 → $18 | Maintains | Buy | |||
10/28/2024 | -7.77% | Jefferies | → $19 | Initiates | → Buy | |||
10/23/2024 | -2.91% | Compass Point | $18 → $20 | Maintains | Buy | |||
10/23/2024 | -17.48% | Canaccord Genuity | $16 → $17 | Maintains | Buy | |||
10/23/2024 | -17.48% | Needham | $16 → $17 | Maintains | Buy | |||
10/11/2024 | -22.33% | Canaccord Genuity | $16 → $16 | Maintains | Buy | |||
10/11/2024 | -32.04% | B. Riley Securities | $13 → $14 | Maintains | Buy | |||
10/03/2024 | -2.91% | Cantor Fitzgerald | $20 → $20 | Reiterates | Overweight → Overweight | |||
09/25/2024 | — | Macquarie | — | Initiates | → Outperform | |||
09/23/2024 | -22.33% | Canaccord Genuity | → $16 | Initiates | → Buy | |||
09/10/2024 | -17.48% | Bernstein | $17 → $17 | Reiterates | Outperform → Outperform | |||
09/04/2024 | -22.33% | Needham | → $16 | Initiates | → Buy | |||
09/03/2024 | -2.91% | Cantor Fitzgerald | $20 → $20 | Reiterates | Overweight → Overweight | |||
08/08/2024 | -2.91% | Cantor Fitzgerald | $20 → $20 | Reiterates | Overweight → Overweight | |||
07/17/2024 | -36.89% | B. Riley Securities | $0.5 → $13 | Upgrade | Neutral → Buy | |||
07/17/2024 | -2.91% | Cantor Fitzgerald | → $20 | Initiates | → Overweight | |||
07/11/2024 | -27.18% | HC Wainwright & Co. | $15 → $15 | Reiterates | Buy → Buy | |||
07/10/2024 | -27.18% | HC Wainwright & Co. | $11 → $15 | Maintains | Buy | |||
07/10/2024 | -17.48% | Bernstein | → $17 | Initiates | → Outperform | |||
07/02/2024 | -29.61% | Ladenburg Thalmann | → $14.5 | Reinstates | → Buy | |||
06/26/2024 | -27.18% | BTIG | $10 → $15 | Maintains | Buy | |||
06/25/2024 | -46.6% | HC Wainwright & Co. | $5 → $11 | Maintains | Buy | |||
06/06/2024 | -51.46% | BTIG | $8 → $10 | Maintains | Buy | |||
05/29/2024 | -61.17% | BTIG | → $8 | Upgrade | Neutral → Buy | |||
03/13/2024 | -75.73% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy | |||
01/31/2024 | -58.74% | Compass Point | $1 → $8.5 | Upgrade | Neutral → Buy | |||
01/25/2024 | — | HC Wainwright & Co. | — | Upgrade | Neutral → Buy |
Le dernier objectif de prix pour Core Scientific (NASDAQ:CORZ) a été rapporté par Bernstein le novembre 3, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $24.00 s'attendant à ce que CORZ se rise dans les 12 prochains mois (un possible changement de 16.50% upside). 44 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Core Scientific (NASDAQ:CORZ) a été fournie par Bernstein, et Core Scientific maintenu leur note outperform.
La dernière amélioration pour Core Scientific Inc a eu lieu le octobre 31, 2025 lorsque Macquarie a augmenté leur objectif de prix à $34. Macquarie avait précédemment a neutral pour Core Scientific Inc.
La dernière réduction pour Core Scientific Inc a eu lieu le juillet 14, 2025 lorsque JMP Securities a changé leur objectif de prix de $15 à $15 pour Core Scientific Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Core Scientific, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Core Scientific a été déposée le novembre 3, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 3, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Core Scientific (CORZ) était un maintenu avec un objectif de prix de $17.00 à $24.00. Le prix actuel de Core Scientific (CORZ) est de $20.60, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.